{"id":"https://genegraph.clinicalgenome.org/r/89a239b7-ef53-47c4-86f6-30698e902b56v3.0","type":"EvidenceStrengthAssertion","dc:description":"*NSUN2* was first reported in relation to autosomal recessive syndromic intellectual disability in 2012 (Abbasi-Moheb et al., PMID: 22541559; Khan et al., PMID: 22541562; Martinez et al.,  PMID: 22577224). The clinical presentation includes global developmental delay, intellectual disability, microcephaly, short stature, delayed puberty, infertility, dysmorphic facial features and a wide-range of ocular-related abnormalities. \n\nTwelve *NSUN2* variants (splice site, nonsense, frameshift, missense) that have been reported in 11 probands are included in this curation. Variants in this gene segregated with disease in 14 additional family members. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. Both consanguineous and non-consanguineous families from different ethnicities have been reported. The mechanism for disease is biallelic loss of function. \n\nOf note, an individual with a homozygous frameshift variant in *NSUN2*, scored here, was described as having facial features reminiscent of Noonan syndrome (PMID: 24102521). This assertion was assessed separately by the ClinGen RASopathy Gene Curation Expert Panel and the relationship between *NSUN2* and RASopathies was disputed. \n\n*NSUN2* encodes an RNA methyltransferase that modifies transfer RNAs crucial for protein synthesis. Experimental evidence supporting this gene-disease relationship includes knockout models in mice (PMIDs: 22144916, 25063673, 3438972) and drosophila (PMID: 22541559). \n\nIn summary, there is definitive evidence to support the relationship between *NSUN2* and syndromic intellectual disability. This gene-disease pair was originally evaluated by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on February 6, 2019. It was re-evaluated on October 18, 2023. As a result of this reevaluation, the classification increased from Moderate to Definitive with the addition of new literature (SOP Version 9). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/89a239b7-ef53-47c4-86f6-30698e902b56","GCISnapshot":"https://genegraph.clinicalgenome.org/r/c6878f90-f485-4c44-95d3-a33b0ec9f66f","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:otherTextChange"},{"id":"cg:summaryChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/c6878f90-f485-4c44-95d3-a33b0ec9f66f_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2024-05-10T20:32:04.579Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/c6878f90-f485-4c44-95d3-a33b0ec9f66f_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2023-10-18T16:00:00.000Z","role":"Approver"}],"curationReasons":["RecurationTiming","RecurationNewEvidence"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6878f90-f485-4c44-95d3-a33b0ec9f66f_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe330182-0c0c-41e1-92df-4e3cd49301ac_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe330182-0c0c-41e1-92df-4e3cd49301ac","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24102521","rdfs:label":"Family 2, Proband ","ageType":"AgeAtReport","ageUnit":"Months","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1fa57c7d-cfee-4a68-afa4-a66dfe90e595","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017755.6(NSUN2):c.1020del (p.Gly341ValfsTer15)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658820839"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Bilateral ptosis, hypotonia, and facial features suggestive of Zellweger syndrome. However, plasma very-long-chain fatty acid, phytanic acid, pristanic acid, and pipecolic acid concentrations were within normal levels. Follow up at age of 6 months, he presented with developmental delay and facial features reminiscent of Noonan syndrome. Facial features include blepharophimosis,  hypertelorism,  broad  nasal  bridge,smooth  philtrum  and  downturning  upper  lip.","phenotypes":["obo:HP_0001263","obo:HP_0001290","obo:HP_0001999","obo:HP_0001488"],"previousTesting":true,"previousTestingDescription":"Sequencing of genes in RAS/MAPK pathway (PTPN11, BRAF, HRAS, KRAS, MAPK1, MAPK2, SHOC2, RAF1 and SOS1) was negative.","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2ae6d9a3-1198-49d2-ae28-ce43e3c20e4f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24102521","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fa57c7d-cfee-4a68-afa4-a66dfe90e595"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/2ae6d9a3-1198-49d2-ae28-ce43e3c20e4f","type":"EvidenceLine","dc:description":"Applied a cap of 2 points per variant as per ID/ASD GCEP recommendation to avoid excessive scoring. This downgrade also takes into account the homozygous variant in a consanguineous family.\n\n\nThe same homozygous variant was reported in an affected child from a consanguineous Emirati family (Komara et al., 2015, PMID: 26055038).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ae6d9a3-1198-49d2-ae28-ce43e3c20e4f_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c6878f90-f485-4c44-95d3-a33b0ec9f66f_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0213f2de-d40d-4cfa-837f-e80aea56dd1c_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33084202","rdfs:label":"Japanese family","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/0213f2de-d40d-4cfa-837f-e80aea56dd1c","type":"Family","rdfs:label":"Japanese family","member":{"id":"https://genegraph.clinicalgenome.org/r/c752aee9-6241-43d0-9f67-00dd39210f50","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33084202","rdfs:label":"Patient 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":16,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/19ea3331-165c-45e7-b2b5-73313106788f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017755.6(NSUN2):c.546_547insCT (p.Met183LeufsTer13)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA557619781"}},{"id":"https://genegraph.clinicalgenome.org/r/e01a69d4-842a-480a-859c-c02e818dc380","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017755.6(NSUN2):c.1583del (p.Pro528HisfsTer19)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2673160356"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0004322","obo:HP_0001263","obo:HP_0000319","obo:HP_0001572","obo:HP_0012713","obo:HP_0002714","obo:HP_0000519","obo:HP_0001344","obo:HP_0000276","obo:HP_0000252","obo:HP_0001999"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/30275586-58aa-48b3-8999-573f82bf42b8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33084202","allele":{"id":"https://genegraph.clinicalgenome.org/r/e01a69d4-842a-480a-859c-c02e818dc380"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/ab9bcca6-6c84-4ec2-a07b-673334df315e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33084202","allele":{"id":"https://genegraph.clinicalgenome.org/r/19ea3331-165c-45e7-b2b5-73313106788f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"phenotypeFreeText":"Both individuals presented severe ID, short stature, and microcephaly. Affected siblings share similar dysmorphic facial features including long face, smooth philtrum, full and downturned upper lip, and macrodontia. ","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/c752aee9-6241-43d0-9f67-00dd39210f50"}},{"id":"https://genegraph.clinicalgenome.org/r/2d424c86-e56a-4d84-bfb1-c0af324c9df4_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33084202","rdfs:label":"Pakistani family","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/2d424c86-e56a-4d84-bfb1-c0af324c9df4","type":"Family","rdfs:label":"Pakistani family","member":{"id":"https://genegraph.clinicalgenome.org/r/f53c52ca-bfa7-4582-97de-46f4b9fffbb0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33084202","rdfs:label":"Patient 3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/bc5d7e0f-f536-4fc0-bbda-438ba07fbc7f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017755.6(NSUN2):c.1269dup (p.Val424CysfsTer14)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2578263600"}},"detectionMethod":"Exome sequencing, Sanger sequencing","phenotypeFreeText":"Patient 3 also had long fingers, toes. She had a deep midline coccygeal dimple and bilateral dimples overlying the iliac crests. ","phenotypes":["obo:HP_0000445","obo:HP_0000455","obo:HP_0002066","obo:HP_0001328","obo:HP_0000252","obo:HP_0000964","obo:HP_0012471","obo:HP_0000664","obo:HP_0011968","obo:HP_0001357","obo:HP_0006989","obo:HP_0004322","obo:HP_0003429","obo:HP_0001344"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/72238d3e-e3fc-4ea0-92f6-5c4b8e66c2b3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33084202","allele":{"id":"https://genegraph.clinicalgenome.org/r/bc5d7e0f-f536-4fc0-bbda-438ba07fbc7f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"phenotypeFreeText":"Both siblings presented severe ID, short stature, and microcephaly.","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/f53c52ca-bfa7-4582-97de-46f4b9fffbb0"}},{"id":"https://genegraph.clinicalgenome.org/r/9d1204f6-f377-4824-bbe7-b3e68090b605_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33002343","rdfs:label":"Chinese family","estimatedLodScore":1.58,"family":{"id":"https://genegraph.clinicalgenome.org/r/9d1204f6-f377-4824-bbe7-b3e68090b605","type":"Family","rdfs:label":"Chinese family","member":{"id":"https://genegraph.clinicalgenome.org/r/b26d12b8-598f-40cf-b370-d6e350a1724d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33002343","rdfs:label":"II-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":20,"allele":{"id":"https://genegraph.clinicalgenome.org/r/61fba07d-05b0-4492-9573-e53fde04b3b2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017755.6(NSUN2):c.1004T>A (p.Leu335Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA113729449"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"She crawled at the age of 4.5 years and could walk with help at age of 10 years. Her gait remains unsteady. Only two fingers of each hand could move; thus, she could not hold a pen or chopsticks.","phenotypes":["obo:HP_0001344","obo:HP_0000252","obo:HP_0001238","obo:HP_0000637","obo:HP_0000316","obo:HP_0001249","obo:HP_0001822","obo:HP_0000426","obo:HP_0000508","obo:HP_0002555","obo:HP_0010862","obo:HP_0000141","obo:HP_0001276","obo:HP_0000020","obo:HP_0000448","obo:HP_0000322","obo:HP_0001263","obo:HP_0002607","obo:HP_0004322","obo:HP_0000276","obo:HP_0011968","obo:HP_0003187","obo:HP_0004325","obo:HP_0000347"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8deee06b-1844-4d72-beb5-5e6f2c4765c2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33002343","allele":{"id":"https://genegraph.clinicalgenome.org/r/61fba07d-05b0-4492-9573-e53fde04b3b2"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Family with three patients; all had ID, DD, microcephaly, short stature, facial deformities (long face, prominent nose, high nasal bridge, short philtrum, hypertelorism, ptosis, long palpebral fissures, and micrognathia), hypertonia, feeding difficulties, and elevated creatine kinase-MB.","phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/b26d12b8-598f-40cf-b370-d6e350a1724d"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/96d7d147-cf93-4b34-be38-fae8b9dcf0fe_proband_segregation","type":"FamilyCosegregation","dc:description":"This gene was sequenced after the identification of the locus.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22541559","rdfs:label":"M-314","family":{"id":"https://genegraph.clinicalgenome.org/r/96d7d147-cf93-4b34-be38-fae8b9dcf0fe","type":"Family","rdfs:label":"M-314","member":{"id":"https://genegraph.clinicalgenome.org/r/6e00fa34-5d08-4043-8e58-e44602348387","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22541559","rdfs:label":"M-314 V:1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":61,"allele":{"id":"https://genegraph.clinicalgenome.org/r/565bd6f2-2d23-4650-8228-a175ae3aeabe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017755.6(NSUN2):c.538-11T>G (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913184856"}},"detectionMethod":"For mutation screening, the exons and exon-intron boundaries of RefSeq genes within the linkage interval were sequenced.","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"moderate intellectual disability, short stature, microcephaly, facial dysmorphism, muscular hypertonia","phenotypes":["obo:HP_0002342","obo:HP_0001264","obo:HP_0000252","obo:HP_0004322","obo:HP_0001999"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4c915ba4-81f0-4195-ac6e-310e981ab790_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22541559","allele":{"id":"https://genegraph.clinicalgenome.org/r/565bd6f2-2d23-4650-8228-a175ae3aeabe"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"moderate intellectual disability, short sature, microcephaly, facial dysmorphism, muscular hypertonia","phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0001999","obo:HP_0000252","obo:HP_0002342","obo:HP_0004322","obo:HP_0001264"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/6e00fa34-5d08-4043-8e58-e44602348387"},"publishedLodScore":3.9,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/3a4a2e7b-2ae3-468a-a0f9-a439b9a4c64c_proband_segregation","type":"FamilyCosegregation","dc:description":"All genes sequenced in linkage region","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22541562","rdfs:label":"MR14","family":{"id":"https://genegraph.clinicalgenome.org/r/3a4a2e7b-2ae3-468a-a0f9-a439b9a4c64c","type":"Family","rdfs:label":"MR14","member":{"id":"https://genegraph.clinicalgenome.org/r/e987e19c-34b8-4d59-850e-bef9d283dd2c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22541562","rdfs:label":"MR14 II:3","ageType":"AgeAtReport","ageValue":14,"allele":{"id":"https://genegraph.clinicalgenome.org/r/8a6318dc-cea4-461d-9eb0-416c1ce53d40","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017755.6(NSUN2):c.2035G>A (p.Gly679Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/31678"}},"detectionMethod":"Linkage analysis yielded a LOD of 2.77; all known coding genes within this 2.565 Mb critical\nregion were screened for mutations by sequencing","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"developmental delay, short stature, dysarthric speech, long face, long nose, pointed nose, long chin, pointed chin, tapering fingers, hypertonia, broad gait, bilateral pes cavus, tight left Achiles, right-eye strabismus, Tanner stage 3, smal midline uterus, thin endometrium and ovaries not visible","phenotypes":["obo:HP_0000271","obo:HP_0000486","obo:HP_0004322","obo:HP_0001264","obo:HP_0001252","obo:HP_0001260","obo:HP_0001263"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e4324a13-1f3b-425c-baa8-ba6adf8fef17_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22541562","allele":{"id":"https://genegraph.clinicalgenome.org/r/8a6318dc-cea4-461d-9eb0-416c1ce53d40"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"developmental delay, dysarthric speech, long face, long nose, pointed nose, long chin, pointed chin, tapering fingers, hypertonia, broad gait, bilateral pes cavus, tight left Achiles, right-eye strabismus, Tanner stage 3, smal midline uterus, thin endometrium and ovaries not visible","phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0000271","obo:HP_0000486","obo:HP_0001264","obo:HP_0001260","obo:HP_0004322","obo:HP_0001263","obo:HP_0001252"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/e987e19c-34b8-4d59-850e-bef9d283dd2c"},"publishedLodScore":2.77,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/8e990ec4-5924-4ff7-9069-55ec6521dc41_proband_segregation","type":"FamilyCosegregation","dc:description":"WES identified splice site variant present in 3/4 affected children of first cousins.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22577224","rdfs:label":"Family 1455","estimatedLodScore":1.33,"family":{"id":"https://genegraph.clinicalgenome.org/r/8e990ec4-5924-4ff7-9069-55ec6521dc41","type":"Family","rdfs:label":"Family 1455","member":{"id":"https://genegraph.clinicalgenome.org/r/7b45f702-b24d-4a04-87d5-3ed1433f0e54","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22577224","rdfs:label":"Family 1455 Proband III-2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/9fc07130-494c-4f88-b9a8-e468cb480ea3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017755.6(NSUN2):c.538-1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/37005"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"\"Dubowitz-like syndrome\", small stature, intellectual disability, mild microcephaly, distinct facial appearance (blepharophimosis, broad nasal bridge, hypertelorism, smooth philtrum, downturning upper lip, sloping forehead and micrognathia, eczema). \nBy 1 year of age, growth retardation and developmental delay were noted. Brain MRI unremarkable.","phenotypes":["obo:HP_0000347","obo:HP_0002714","obo:HP_0004322","obo:HP_0000431","obo:HP_0000316","obo:HP_0008850","obo:HP_0000319","obo:HP_0001999","obo:HP_0001263","obo:HP_0040196","obo:HP_0000340","obo:HP_0001249","obo:HP_0000581","obo:HP_0000964"],"previousTesting":true,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/bb92cb37-6722-4b65-94cc-e80312fb596e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22577224","allele":{"id":"https://genegraph.clinicalgenome.org/r/9fc07130-494c-4f88-b9a8-e468cb480ea3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"\"Dubowitz-like syndrome\" small stature,  intellectual disability, mild microcephaly, distinct facial appearance (blepharophimosis, broad nasal bridge, hypertelorism, smooth philtrum, downturning upper lip, sloping forehead and micrognathia, eczema. \nBy 1 year of age, growth retardation and developmental delay were noted.  Brain MRI unremarkable.","phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0000347","obo:HP_0001999","obo:HP_0001263","obo:HP_0004322","obo:HP_0000319","obo:HP_0001249","obo:HP_0008850","obo:HP_0040196","obo:HP_0000581","obo:HP_0002714","obo:HP_0000964","obo:HP_0000316","obo:HP_0000431","obo:HP_0000340"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/7b45f702-b24d-4a04-87d5-3ed1433f0e54"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/abe7b22b-8599-4642-8b10-41299c68ebe4_proband_segregation","type":"FamilyCosegregation","dc:description":"Mutation screening in the complete protein-coding and adjacent intronic regions within MRT5 (family M-192) by Sanger-Sequencing revealed a nonsense mutation, c.679C>T (p.Gln227*) (RefSeq NM_017755.5), affecting NSUN2 (Figures 2Aâ€“2C), which encodes four tRNA-methyltransferase transcripts that are expressed in the brain at\nvarious developmental stages (Figure S2).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22541559","rdfs:label":"M-192","estimatedLodScore":1.95,"family":{"id":"https://genegraph.clinicalgenome.org/r/abe7b22b-8599-4642-8b10-41299c68ebe4","type":"Family","rdfs:label":"M-192","member":{"id":"https://genegraph.clinicalgenome.org/r/1efd1e9c-15b9-4e86-99f7-21e04e49677d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22541559","rdfs:label":"M-192 V:3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":29,"allele":{"id":"https://genegraph.clinicalgenome.org/r/50f4ef3d-3fba-455e-98cc-da91e207c051","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017755.6(NSUN2):c.679C>T (p.Gln227Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129880"}},"detectionMethod":"For mutation screening, the exons and exon-intron boundaries of RefSeq genes within the  linkage intervals were sequenced.","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"moderate intellectual disability, microcephaly, facial dysmorphism, muscular hypotonia","phenotypes":["obo:HP_0001252","obo:HP_0000252","obo:HP_0001999","obo:HP_0001249"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6582ac89-66e5-4ff6-ab2d-583503b91f3c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22541559","allele":{"id":"https://genegraph.clinicalgenome.org/r/50f4ef3d-3fba-455e-98cc-da91e207c051"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"intellectual disabilty, short stature, microcephaly, facial dysmorphism, muscular hypotonia","phenotypeNegativeAlleleNegative":6,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0000252","obo:HP_0001249","obo:HP_0001252","obo:HP_0004322","obo:HP_0001999"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/1efd1e9c-15b9-4e86-99f7-21e04e49677d"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/5288f405-b797-481f-90da-02d2323d9b04_proband_segregation","type":"FamilyCosegregation","dc:description":"This family was screened for the NSUN2 variants after the nonsense variant was identified in the other family that had the entire linkage region sequenced.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22541559","rdfs:label":"G-013 Family","family":{"id":"https://genegraph.clinicalgenome.org/r/5288f405-b797-481f-90da-02d2323d9b04","type":"Family","rdfs:label":"G-013 Family","member":{"id":"https://genegraph.clinicalgenome.org/r/27870a83-cab5-4727-a9fe-99dadbd3783e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22541559","rdfs:label":"G-013 IV:5","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/82333dd7-d18f-44f2-a224-6fc3dc4ae904","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017755.6(NSUN2):c.1114C>T (p.Gln372Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129882"}},"detectionMethod":"For mutation screening, the exons and exon-intron boundaries of RefSeq genes within the linkage interval were sequenced.","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"moderate intellectual disability, short stature, microcephaly, facial dysmorphism, strabismus","phenotypes":["obo:HP_0000252","obo:HP_0002342","obo:HP_0004322","obo:HP_0001264","obo:HP_0001999"],"previousTesting":true,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/79c1b9b2-0624-47c9-8470-8452453045d1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22541559","allele":{"id":"https://genegraph.clinicalgenome.org/r/82333dd7-d18f-44f2-a224-6fc3dc4ae904"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"moderate intellectual disability, short stature, microcephaly, facial dysmorphism, muscular hypertonia","phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0004322","obo:HP_0002342","obo:HP_0000252","obo:HP_0000271","obo:HP_0000486","obo:HP_0001264"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/27870a83-cab5-4727-a9fe-99dadbd3783e"},"publishedLodScore":2.3,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/1efd1e9c-15b9-4e86-99f7-21e04e49677d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1efd1e9c-15b9-4e86-99f7-21e04e49677d"},{"id":"https://genegraph.clinicalgenome.org/r/6582ac89-66e5-4ff6-ab2d-583503b91f3c","type":"EvidenceLine","dc:description":"Applied a cap of 2 points per variant as per ID/ASD GCEP recommendation to avoid excessive scoring. This downgrade also takes into account the homozygous variant in a consanguineous family.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6582ac89-66e5-4ff6-ab2d-583503b91f3c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/6582ac89-66e5-4ff6-ab2d-583503b91f3c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Quantitative RT-PCR shows loss of NSUN2 transcription in an individual homozygous for Gln227Ter. RNA was extracted from transformed lymphoblastoid cell lines.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b26d12b8-598f-40cf-b370-d6e350a1724d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b26d12b8-598f-40cf-b370-d6e350a1724d"},{"id":"https://genegraph.clinicalgenome.org/r/8deee06b-1844-4d72-beb5-5e6f2c4765c2","type":"EvidenceLine","dc:description":"Applied a cap of 2 points per variant as per ID/ASD GCEP recommendation to avoid excessive scoring. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8deee06b-1844-4d72-beb5-5e6f2c4765c2_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/7b45f702-b24d-4a04-87d5-3ed1433f0e54_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b45f702-b24d-4a04-87d5-3ed1433f0e54"},{"id":"https://genegraph.clinicalgenome.org/r/bb92cb37-6722-4b65-94cc-e80312fb596e","type":"EvidenceLine","dc:description":"Applied a cap of 2 points per variant as per ID/ASD GCEP recommendation to avoid excessive scoring. This downgrade also takes into account the homozygous variant in a consanguineous family.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb92cb37-6722-4b65-94cc-e80312fb596e_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/bb92cb37-6722-4b65-94cc-e80312fb596e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Quantitative RT-PCR was performed on dermal fibroblasts obtained from two affected individuals, the mother, and one unrelated control. Found a severe reduction in NSUN2 mRNA levels in affected individuals (Fig 2). c.538-1G>C variant causes out-of-frame skipping leading to NMD confirmed by Western blot, which shows undetectable NSUN2 protein levels in affected cell lines from Family-1455. (Fig 3).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/27870a83-cab5-4727-a9fe-99dadbd3783e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/27870a83-cab5-4727-a9fe-99dadbd3783e"},{"id":"https://genegraph.clinicalgenome.org/r/79c1b9b2-0624-47c9-8470-8452453045d1","type":"EvidenceLine","dc:description":"Applied a cap of 2 points per variant as per ID/ASD GCEP recommendation to avoid excessive scoring. This downgrade also takes into account the homozygous variant in a consanguineous family.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/79c1b9b2-0624-47c9-8470-8452453045d1_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/79c1b9b2-0624-47c9-8470-8452453045d1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Quantitative RT-PCR shows loss of NSUN2 transcription in an individual homozygous for Gln372Ter. RNA was extracted from transformed lymphoblastoid cell lines.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3d070ae9-f19a-4ce4-9c3a-368fbbe7c48b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3d070ae9-f19a-4ce4-9c3a-368fbbe7c48b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35126837","rdfs:label":"Pingree case report","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/e727a26f-ff13-4596-a11c-39ba7f6dccdb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017755.6(NSUN2):c.360-1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA359127860"}},{"id":"https://genegraph.clinicalgenome.org/r/c94463d5-8d9d-4cbc-9ae8-563a74fb58ae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017755.6(NSUN2):c.787G>T (p.Asp263Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA113737448"}}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Low tone was noted shortly after birth, and the patient had difficulty with feeding. Early feeding therapy improved his oral-motor dysfunction. At 12 months, it was observed that the patient had several unique features including clinodactyly of the fifth digit and abnormal helices. A MRI of the brain was unremarkable. \nBy three years of age his motor skills, proprioception, and kinesthetic awareness were all at the level expected for a 24-month-old. Currently at age four, the patient remains nonverbal and demonstrates chronic dysphagia, difficulty walking, and hearing problems. Spontaneous improvement in his epiblepharon was noted in both eyes.","phenotypes":["obo:HP_0011225","obo:HP_0002015","obo:HP_0001252","obo:HP_0001999","obo:HP_0001263","obo:HP_0001249","obo:HP_0000486","obo:HP_0000365","obo:HP_0001270","obo:HP_0025144"],"previousTesting":false,"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/f9df583a-392e-424a-b62a-9dd116678bd7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35126837","allele":{"id":"https://genegraph.clinicalgenome.org/r/e727a26f-ff13-4596-a11c-39ba7f6dccdb"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/a4398ae2-e0a3-40d8-81f4-5424dc6a733e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35126837","allele":{"id":"https://genegraph.clinicalgenome.org/r/c94463d5-8d9d-4cbc-9ae8-563a74fb58ae"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/f9df583a-392e-424a-b62a-9dd116678bd7","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f9df583a-392e-424a-b62a-9dd116678bd7_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a4398ae2-e0a3-40d8-81f4-5424dc6a733e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a4398ae2-e0a3-40d8-81f4-5424dc6a733e_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/c752aee9-6241-43d0-9f67-00dd39210f50_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c752aee9-6241-43d0-9f67-00dd39210f50"},{"id":"https://genegraph.clinicalgenome.org/r/ab9bcca6-6c84-4ec2-a07b-673334df315e","type":"EvidenceLine","dc:description":"Applied a cap of 2 points as per ID/ASD GCEP recommendation to avoid excessive scoring for each case.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ab9bcca6-6c84-4ec2-a07b-673334df315e_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/30275586-58aa-48b3-8999-573f82bf42b8","type":"EvidenceLine","dc:description":"Applied a cap of 2 points as per ID/ASD GCEP recommendation to avoid excessive scoring for each case.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/30275586-58aa-48b3-8999-573f82bf42b8_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f53c52ca-bfa7-4582-97de-46f4b9fffbb0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f53c52ca-bfa7-4582-97de-46f4b9fffbb0"},{"id":"https://genegraph.clinicalgenome.org/r/72238d3e-e3fc-4ea0-92f6-5c4b8e66c2b3","type":"EvidenceLine","dc:description":"Applied a cap of 2 points per variant as per ID/ASD GCEP recommendation to avoid excessive scoring.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/72238d3e-e3fc-4ea0-92f6-5c4b8e66c2b3_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e987e19c-34b8-4d59-850e-bef9d283dd2c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e987e19c-34b8-4d59-850e-bef9d283dd2c"},{"id":"https://genegraph.clinicalgenome.org/r/e4324a13-1f3b-425c-baa8-ba6adf8fef17","type":"EvidenceLine","dc:description":"Downgraded to 0.5 points due to presence of homozygous variant in a consanguineous family","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4324a13-1f3b-425c-baa8-ba6adf8fef17_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/e4324a13-1f3b-425c-baa8-ba6adf8fef17_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant was shown to impair proper cellular localization of the NSUN2 protein; p.Gly679Arg mutant failed to localize to the nucleoli in most transfected Human Breast Cancer Cell Line HCC1954, and accumulated in the nucleoplasm in 80% of transfected cells.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6e00fa34-5d08-4043-8e58-e44602348387_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6e00fa34-5d08-4043-8e58-e44602348387"},{"id":"https://genegraph.clinicalgenome.org/r/4c915ba4-81f0-4195-ac6e-310e981ab790","type":"EvidenceLine","dc:description":"Applied a cap of 2 points per variant as per ID/ASD GCEP recommendation to avoid excessive scoring. This downgrade also takes into account the homozygous variant in a consanguineous family.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c915ba4-81f0-4195-ac6e-310e981ab790_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/4c915ba4-81f0-4195-ac6e-310e981ab790_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Using RT-PCR, this variant was found to cause a frameshift that results in skipping of exon 6 and causes a stop codon in exon 7 due to a frameshift (p.Ile179Argfs*192). RT-PCR results show loss of main transcript in affected individuals.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/c6878f90-f485-4c44-95d3-a33b0ec9f66f_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6878f90-f485-4c44-95d3-a33b0ec9f66f_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e69245e7-ce39-4b7d-8d6d-5c4b3f869ed0","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7de5072d-a8e8-4ffd-8f84-a34bd851f420","type":"Finding","dc:description":"Mice with conditional ablation of Nsun2 in excitatory neurons (CamK-Cre+,Nsun22lox/2lox mutant mice) exhibited a decrease in tRNA cytosine methylation in the adult cortex and glycine codon-specific defects in translational efficiency. This caused decreased expression of glycine-rich synaptic proteins critical for glutamatergic neurotransmission, associated with impaired synaptic signaling at prefrontal cortex pyramidal neurons and defective contextual fear memory. Changes in the neuronal translatome were also associated with an increase in glycine biosynthesis in the mutant cortex.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34389722","rdfs:label":"Neuronal Nsun2 deficiency in mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c2e1bc65-e9df-45d6-a035-1b6678acbe8c","type":"EvidenceLine","dc:description":"Downgraded because non-mammalian model, as per ID/ASD GCEP.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1e99636b-00e1-496c-8a63-5ee6805bdbec","type":"Finding","dc:description":"A Drosophila model with deletion of the NSUN2 ortholog, CG6133, exhibited severe short-term-memory deficits that were rescued by re-expression of the wild-type protein in the nervous system.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22541559","rdfs:label":"Nsun2 Drosophila model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/246ec782-0fca-4307-b901-d607cbca2c80","type":"EvidenceLine","dc:description":"This mouse model recapitulates two features observed in affected individuals. They also had reduced brain size due to excessive cell death in the prenatal brain. The score was downgraded due to the lack of characterization of nervous system deficits. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8ec190d4-8b2d-4c64-89db-f4d4bab2dad7","type":"Finding","dc:description":"Nsun2-/- mice exhibited small size and infertility. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22144916","rdfs:label":"Nsun2 knockout mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/87a14d76-71f7-40c2-aa82-765480776f31","type":"EvidenceLine","dc:description":"This same mouse model was reported in Blanco et al. (2011) as exhibiting small size and infertility and awarded 0.5 points (see below). We are awarding 1.5 points to these new findings so overall the knockout model gets the default 2 points.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b5821f9-d296-42b0-8b9f-e5021c620b33","type":"Finding","dc:description":"NSun2-/- mice showed a reduction of spontaneous alternations in the Y maxe test, which suggests deficient spatial working memory. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25063673","rdfs:label":"NSun2 deletion causes neurodevelopmental defects in mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4}],"evidenceStrength":"Definitive","sequence":8281,"specifiedBy":"GeneValidityCriteria9","strengthScore":16,"subject":{"id":"https://genegraph.clinicalgenome.org/r/DQr9fHsKuMo","type":"GeneValidityProposition","disease":"obo:MONDO_0000508","gene":"hgnc:25994","modeOfInheritance":"obo:HP_0000007"},"version":"3.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_c6878f90-f485-4c44-95d3-a33b0ec9f66f-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}